Literature DB >> 1517282

Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index.

P K Lipponen1, M J Eskelinen, K Jauhiainen, E Harju, P Terho, H Haapasalo.   

Abstract

A retrospective histological analysis has been carried out on 537 cases of transitional-cell bladder carcinoma, followed-up over a period of 9 years. In the first part of the study WHO grade 2 tumours were analysed and a number of independent factors predictive for survival identified. In a multivariate analysis the T category and M/V index (number of mitotic figures/mm2 neoplastic epithelium) were the most important prognostic factors. In a subsequent analysis of the whole series of 537 cases, overall the M/V index was not as important in predicting survival as the stage of the tumour. However, in superficial tumours (Ta-T1) subsequent analysis showed that the M/V index alone could be used to predict survival.

Entities:  

Mesh:

Year:  1992        PMID: 1517282     DOI: 10.1007/bf01211807

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

1.  DNA ploidy and the prognosis of stage pT1 bladder cancer.

Authors:  J R Masters; R S Camplejohn; M C Parkinson; C R Woodhouse
Journal:  Br J Urol       Date:  1989-10

2.  Relationship between DNA flow cytometric data, nuclear morphometric variables and volume-corrected mitotic index in transitional cell bladder tumors.

Authors:  P K Lipponen; M J Eskelinen; S Nordling
Journal:  Eur Urol       Date:  1991       Impact factor: 20.096

3.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.

Authors:  A Bergkvist; A Ljungqvist; G Moberger
Journal:  Acta Chir Scand       Date:  1965-10

Review 4.  An overview of intravesical therapy for superficial bladder tumors.

Authors:  H W Herr; V P Laudone; W F Whitmore
Journal:  J Urol       Date:  1987-12       Impact factor: 7.450

5.  Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry.

Authors:  A A Shaaban; B Tribukait; A F el-Bedeiwy; M A Ghoneim
Journal:  J Urol       Date:  1990-10       Impact factor: 7.450

6.  Prediction of superficial bladder cancer by histoquantitative methods.

Authors:  P K Lipponen; M J Eskelinen; M Sotarauta
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

7.  Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder.

Authors:  P K Lipponen; V M Kosma; Y Collan; T Kulju; O Kosunen; M Eskelinen
Journal:  Eur Urol       Date:  1990       Impact factor: 20.096

8.  Prognostic factors in human pancreatic cancer, with special reference to quantitative histology.

Authors:  M Eskelinen; P Lipponen; S Marin; H Haapasalo; K Mäkinen; H Ahtola; J Puittinen; P Nuutinen; E Alhava
Journal:  Scand J Gastroenterol       Date:  1991-05       Impact factor: 2.423

9.  The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma.

Authors:  E C Blomjous; N W Schipper; J P Baak; W Vos; H J De Voogt; C J Meijer
Journal:  Am J Clin Pathol       Date:  1989-03       Impact factor: 2.493

10.  Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms.

Authors:  H Haapasalo; E Pesonen; Y Collan
Journal:  Pathol Res Pract       Date:  1989-11       Impact factor: 3.250

View more
  3 in total

1.  Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.

Authors:  T J Liukkonen; P K Lipponen; M Helle; H K Haapasalo; S Nordling; P Rajala
Journal:  Urol Res       Date:  1996

2.  Diagnostic roles of proliferative markers in pathological Grade of T1 Urothelial Bladder Cancer.

Authors:  Jianping Yang; Chunjun Li; Yong Tang; Fang Guo; Yu Chen; Wenqi Luo; Xiaoyu Chen; Yun Ma; Lixia Zeng
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

3.  Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.

Authors:  S Vesalainen; S Nordling; P Lipponen; M Talja; K Syrjänen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.